Received: 5 December 2018
Accepted: 1 April 2019
First Online: 24 April 2019
Ethics approval and consent to participate
: The trial was approved by the New Zealand Ministry of Health, Health and Disability Ethics Committees (14/CEN/117) and all participants provided written informed consent.
: Not applicable.
: N. D. has received consulting fees, speaker fees or grants from Takeda, Teijin, Menarini, Amgen, Ardea Biosciences, AstraZeneca, Horizon, Cymabay and Kowa, outside the submitted work. K. R. has received funding from ASICS, outside the submitted work. ASICS had no role in the design of the study. The footwear used in the study was purchased at retail price. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.